Compare metabolites in 2 of these studies:
Study A:   Study B:  

List of Studies ( Metabolite:Sedoheptulose 1,7-bisphosphate)

Study_idAnalysis_idStudy_titleSourceSpeciesDiseaseInstituteUnits(range)
ST002759 AN004480 Metabolic responses of normal rat kidneys to a high salt intake (Kidney cortex) Kidney cortex Rat Medical College of Wisconsin Area
ST002760 AN004484 Metabolic responses of normal rat kidneys to a high salt intake (Kidney outer medulla) Kidney outer medulla Rat Medical College of Wisconsin Area
ST002245 AN003665 Deciphering the metabolomic differences between two fast-growing cyanobacteria, S.elongatus PCC 11801 and 11802 via metabolite profiling Bacterial cells Synechococcus elongatus Indian Institute of Technology Bombay Area Ratios
ST001850 AN002997 Unbiased LC-MS-based metabolomics analysis for both whole cell and mitochondria metabolites to gain an insight into the role of Tug1/PGC1 axis on metabolite profiles in podocytes Epithelial cells Mouse University of Texas MD Anderson Cancer Center AUC/ngDNA
ST002119 AN003468 Metabolomics analysis of zebrafish response to CID661578 treatment Larvae Zebrafish Diabetes North Carolina State University ion counts
ST001660 AN002711 Plasmodium falciparum metabolomics as a result of treatment with putative acetyl-CoA synthetase inhibitors Cultured cells Plasmodium falciparum Malaria Pennsylvania State University Normalized and blank subtracted peak area
ST001985 AN003236 Profiling Plasmodium falciparum parasites and human red blood cells after treatment with MMV693183 Blood Human Malaria Pennsylvania State University Peak Abundance (normalized, blank subtracted, and corrected for baseline noise)
ST001985 AN003236 Profiling Plasmodium falciparum parasites and human red blood cells after treatment with MMV693183 Blood Plasmodium falciparum Malaria Pennsylvania State University Peak Abundance (normalized, blank subtracted, and corrected for baseline noise)
ST001985 AN003236 Profiling Plasmodium falciparum parasites and human red blood cells after treatment with MMV693183 Cultured cells Human Malaria Pennsylvania State University Peak Abundance (normalized, blank subtracted, and corrected for baseline noise)
ST001985 AN003236 Profiling Plasmodium falciparum parasites and human red blood cells after treatment with MMV693183 Cultured cells Plasmodium falciparum Malaria Pennsylvania State University Peak Abundance (normalized, blank subtracted, and corrected for baseline noise)
ST002024 AN003294 Plasmodium falciparum stable-isotope carbon labeling to explore metabolic consequences of keto–acid dehydrogenase disruption Cultured cells Plasmodium falciparum Malaria Pennsylvania State University Peak Abundance (normalized, blank subtracted, and corrected for baseline noise)
ST002011 AN003277 The anticancer human mTOR inhibitor MLN0128/Sapanisertib with potent multistage in vitro antiplasmodium activity and in vivo antimalarial efficacy in a humanised mouse model is an inhibitor of multiple Plasmodium falciparum kinases. Blood Plasmodium falciparum Malaria Pennsylvania State University peak area
ST002011 AN003278 The anticancer human mTOR inhibitor MLN0128/Sapanisertib with potent multistage in vitro antiplasmodium activity and in vivo antimalarial efficacy in a humanised mouse model is an inhibitor of multiple Plasmodium falciparum kinases. Blood Plasmodium falciparum Malaria Pennsylvania State University peak area
ST002011 AN003279 The anticancer human mTOR inhibitor MLN0128/Sapanisertib with potent multistage in vitro antiplasmodium activity and in vivo antimalarial efficacy in a humanised mouse model is an inhibitor of multiple Plasmodium falciparum kinases. Blood Plasmodium falciparum Malaria Pennsylvania State University peak area
ST002078 AN003387 Multiple modes of interfering with the activity of Plasmodium falciparum cytoplasmic isoleucyl-tRNA synthetase illustrate the enzyme is a promising antimalarial target. Cultured cells Plasmodium falciparum Malaria Pennsylvania State University peak area
ST002078 AN003388 Multiple modes of interfering with the activity of Plasmodium falciparum cytoplasmic isoleucyl-tRNA synthetase illustrate the enzyme is a promising antimalarial target. Cultured cells Plasmodium falciparum Malaria Pennsylvania State University peak area
ST002078 AN003389 Multiple modes of interfering with the activity of Plasmodium falciparum cytoplasmic isoleucyl-tRNA synthetase illustrate the enzyme is a promising antimalarial target. Cultured cells Plasmodium falciparum Malaria Pennsylvania State University peak area
ST002078 AN003390 Multiple modes of interfering with the activity of Plasmodium falciparum cytoplasmic isoleucyl-tRNA synthetase illustrate the enzyme is a promising antimalarial target. Cultured cells Plasmodium falciparum Malaria Pennsylvania State University peak area
ST002371 AN003866 High-resolution metabolomics analysis of NLRP3 inflammasome activated macrophages Macrophages Mouse Inflammation Wake Forest School of Medicine peak area
ST000116 AN000197 Comparative metabolomics analysis of the key metabolic nodes in propionic acid synthesis in Propionibacterium acidipropionici Bacterial cells Propionibacterium Jiangnan University Peak area
ST000142 AN000225 H1299 13C-labeled Cell Study Lung Human Cancer University of Kentucky Peak area
ST001611 AN002646 Mouse model of sarcoma (STS) to characterize tumor vulnerabilities and identify novel targets for anti-cancer treatment Muscle Mouse Cancer North Carolina State University Peak area
ST001611 AN002646 Mouse model of sarcoma (STS) to characterize tumor vulnerabilities and identify novel targets for anti-cancer treatment Sarcoma Mouse Cancer North Carolina State University Peak area
ST001149 AN001896 Plasmodium Niemann-Pick Type C1-Related Protein is a Druggable Target Required for Parasite Membrane Homeostasis Cultured cells Plasmodium falciparum Malaria Pennsylvania State University Peak Area Post-Blank Subtraction
ST001180 AN001958 Metabolome Profiling of Synechococcus elogatus PCC 11802 Cultured cells Synechococcus elongatus Indian Institute of Technology, Bombay Peak area ratio
ST001298 AN002162 Metabolome Profiling of Synechococcus elongatus PCC 11801 strains engineered for Succinate Production Bacterial cells Synechococcus elongatus Indian Institute of Technology Bombay (IIT Bombay) Peak area ratio
ST001302 AN002168 Metabolome Profiling of a Fast-growing Cyanobacterium Synechococcus elongatus PCC 11801 under Diurnal Cycle Bacterial cells Synechococcus Indian Institute of Technology Bombay Peak area ratio
ST002115 AN003513 LC-MS analysis of metabolic changes induced by GPX4 inhibitor treatment in cultured HT1080 cells Cultured cells Human University of Texas MD Anderson Cancer Center Peak area (top)
ST001274 AN002115 Metabolomics-based profiling of the mode of action of Pathogen Box compounds in Trypanosoma brucei (part-I) Cultured cells Trypanosoma brucei Sleeping sickness Monash University Peak height
ST001201 AN001999 Peroxide antimalarial treatment timecourse on trophozoite-stage P. falciparum parasites Cultured cells Human Malaria Monash University Peak intensity
ST001201 AN001999 Peroxide antimalarial treatment timecourse on trophozoite-stage P. falciparum parasites Cultured cells Plasmodium falciparum Malaria Monash University Peak intensity
ST001202 AN002001 Peroxide antimalarial treatment timecourse on ring-stage P. falciparum parasites Cultured cells Human Malaria Monash University Peak intensity
ST001202 AN002001 Peroxide antimalarial treatment timecourse on ring-stage P. falciparum parasites Cultured cells Plasmodium falciparum Malaria Monash University Peak intensity
ST001204 AN002005 Peroxide antimalarial extended treatment timecourse on trophozoite-stage P. falciparum parasites Cultured cells Human Malaria Monash University Peak intensity
ST001204 AN002005 Peroxide antimalarial extended treatment timecourse on trophozoite-stage P. falciparum parasites Cultured cells Plasmodium falciparum Malaria Monash University Peak intensity
ST001205 AN002007 Peroxide antimalarial treatment of K13-mutant and -wildtype P. falciparum parasites Cultured cells Human Malaria Monash University Peak intensity
ST001205 AN002007 Peroxide antimalarial treatment of K13-mutant and -wildtype P. falciparum parasites Cultured cells Plasmodium falciparum Malaria Monash University Peak intensity
ST001549 AN002581 β-Adrenergic regulation of metabolism in macrophages (part-III) Macrophages Human Monash University Peak intensity
ST002541 AN004187 Methionine restriction constrains lipoylation and activates mitochondria for nitrogenic synthesis of amino acids (Part 1) Yeast cells Yeast Life Sciences Institute, ZheJiang University Peak intensity
ST002542 AN004189 Methionine restriction constrains lipoylation and activates mitochondria for nitrogenic synthesis of amino acids (Part 2) Yeast cells Yeast Life Sciences Institute, ZheJiang University Peak intensity
ST002805 AN004561 IL-1β-mediated adaptive re-programming of endogenous human cardiac fibroblasts to cells with immune features during fibrotic remodeling Cultured cells Human Pulmonary hypertension Brown University Q3 Peak Area (area under curve)
ST002108 AN003449 Genetic and chemical validation of Plasmodium falciparum aminopeptidase PfA-M17 as a drug target in the hemoglobin digestion pathway (Part 3) Blood Plasmodium falciparum Malaria Monash University relative intensity
ST001377 AN002297 Stirred suspension bioreactors maintain naïve pluripotency of human pluripotent stem cells (hPSCs) Stem cells Human University of Calgary relative signal intensity compared to media only
  logo